Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report) General Counsel Philip Mazzara sold 50,000 shares of Astera Labs stock in a transaction that occurred on Thursday, February 20th. The shares were sold at an average price of $87.46, for a total value of $4,373,000.00. Following the completion of the transaction, the general counsel now owns 191,209 shares in the company, valued at $16,723,139.14. This trade represents a 20.73 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.
Philip Mazzara also recently made the following trade(s):
- On Tuesday, February 18th, Philip Mazzara sold 7,536 shares of Astera Labs stock. The shares were sold at an average price of $92.07, for a total value of $693,839.52.
Astera Labs Stock Performance
ALAB opened at $85.72 on Friday. Astera Labs, Inc. has a one year low of $36.22 and a one year high of $147.39. The company has a market cap of $13.90 billion and a price-to-earnings ratio of -49.55. The business’s fifty day moving average is $116.72 and its two-hundred day moving average is $84.84.
Wall Street Analysts Forecast Growth
A number of analysts recently weighed in on the company. Craig Hallum lifted their price target on Astera Labs from $105.00 to $125.00 and gave the company a “buy” rating in a research note on Tuesday, February 11th. Needham & Company LLC restated a “buy” rating and issued a $140.00 price target on shares of Astera Labs in a research note on Tuesday, February 11th. Northland Securities upgraded Astera Labs from a “market perform” rating to an “outperform” rating and set a $120.00 price target on the stock in a research note on Tuesday, January 28th. Citigroup assumed coverage on Astera Labs in a research note on Monday, November 18th. They issued a “buy” rating and a $120.00 price target on the stock. Finally, Barclays lifted their price target on Astera Labs from $87.00 to $135.00 and gave the company an “overweight” rating in a research note on Friday, January 17th. One investment analyst has rated the stock with a hold rating, eleven have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average price target of $115.33.
Read Our Latest Stock Report on Astera Labs
Hedge Funds Weigh In On Astera Labs
Institutional investors have recently made changes to their positions in the stock. Whittier Trust Co. of Nevada Inc. acquired a new position in shares of Astera Labs in the fourth quarter worth $25,000. Steward Partners Investment Advisory LLC raised its holdings in shares of Astera Labs by 99.0% in the fourth quarter. Steward Partners Investment Advisory LLC now owns 199 shares of the company’s stock worth $26,000 after acquiring an additional 99 shares during the last quarter. Kestra Investment Management LLC acquired a new position in shares of Astera Labs in the fourth quarter worth $28,000. Geneos Wealth Management Inc. acquired a new position in Astera Labs in the fourth quarter valued at $36,000. Finally, Global Retirement Partners LLC increased its stake in Astera Labs by 3,155.6% in the fourth quarter. Global Retirement Partners LLC now owns 293 shares of the company’s stock valued at $39,000 after purchasing an additional 284 shares during the last quarter. 60.47% of the stock is owned by institutional investors and hedge funds.
About Astera Labs
Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
See Also
- Five stocks we like better than Astera Labs
- Using the MarketBeat Stock Split Calculator
- 3 Stocks Poised to Thrive as NVIDIA Dominates the AI Boom
- Where to Find Earnings Call Transcripts
- MercadoLibre: High-Growth EM Stock With 100% Upside Potential
- How to Use the MarketBeat Dividend Calculator
- As the Magnificent 7 Stalls, These 3 Stocks Are Gaining Momentum
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.